Does LEVODOPA Cause Therapeutic product effect variable? 298 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 298 reports of Therapeutic product effect variable have been filed in association with LEVODOPA (L-Dopa). This represents 4.5% of all adverse event reports for LEVODOPA.
298
Reports of Therapeutic product effect variable with LEVODOPA
4.5%
of all LEVODOPA reports
1
Deaths
20
Hospitalizations
How Dangerous Is Therapeutic product effect variable From LEVODOPA?
Of the 298 reports, 1 (0.3%) resulted in death, 20 (6.7%) required hospitalization.
Is Therapeutic product effect variable Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVODOPA. However, 298 reports have been filed with the FAERS database.
What Other Side Effects Does LEVODOPA Cause?
Cough (2,142)
Drug ineffective (1,036)
Parkinson's disease (761)
Device issue (565)
Product residue present (534)
Device difficult to use (466)
Condition aggravated (463)
Device use issue (443)
Dyskinesia (411)
Death (335)
What Other Drugs Cause Therapeutic product effect variable?
CARBIDOPA\LEVODOPA (316)
RIMEGEPANT (177)
GABAPENTIN (166)
CLOZAPINE (157)
DICLOFENAC (153)
OLANZAPINE (150)
FLUOXETINE (149)
ARIPIPRAZOLE (148)
AMISULPRIDE (147)
LOXAPINE (147)
Which LEVODOPA Alternatives Have Lower Therapeutic product effect variable Risk?
LEVODOPA vs LEVOFLOXACIN
LEVODOPA vs LEVOKETOCONAZOLE
LEVODOPA vs LEVOLEUCOVORIN
LEVODOPA vs LEVOMEPROMAZINE
LEVODOPA vs LEVOMETHADONE